尼加拉瓜莱昂市基于城市人口队列的 SARS-CoV-2 感染血清流行病学。
Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in León, Nicaragua.
机构信息
Center for Infectious Diseases Research, National Autonomous University of Nicaragua - León, León, Nicaragua.
Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
出版信息
Epidemiol Infect. 2021 Oct 20;149:e247. doi: 10.1017/S0950268821002144.
Abstract
In a Nicaraguan population-based cohort, SARS-CoV-2 seroprevalence reached 28% in the first 6 months of the country's epidemic and reached 35% 6 months later. Immune waning was uncommon. Individuals with a seropositive household member were over three times as likely to be seropositive themselves, suggesting the importance of household transmission.
摘要
在尼加拉瓜基于人群的队列研究中，该国疫情的前 6 个月，SARS-CoV-2 血清阳性率达到 28%，6 个月后达到 35%。免疫衰减并不常见。家中有血清学阳性成员的个体自身呈血清学阳性的可能性是其三倍以上，这表明家庭传播的重要性。
相似文献
1
Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in León, Nicaragua.
Epidemiol Infect. 2021 Oct 20;149:e247. doi: 10.1017/S0950268821002144.
2
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.
Nat Commun. 2022 Feb 1;13(1):589. doi: 10.1038/s41467-022-28232-9.
3
SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Viruses. 2021 Aug 19;13(8):1648. doi: 10.3390/v13081648.
4
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
JAMA Netw Open. 2021 Nov 1;4(11):e2135975. doi: 10.1001/jamanetworkopen.2021.35975.
5
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24.
6
Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends.
Z Naturforsch C J Biosci. 2021 Jun 22;76(9-10):425-429. doi: 10.1515/znc-2020-0291. Print 2021 Sep 27.
7
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
8
Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a cross-sectional survey.
BMJ Open. 2021 Sep 21;11(9):e051836. doi: 10.1136/bmjopen-2021-051836.
9
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
10
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.
S Afr Med J. 2021 Nov 5;111(11):1078-1083. doi: 10.7196/SAMJ.2021.v111i11.15669.
引用本文的文献
1
Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica.
Commun Med (Lond). 2023 Jul 22;3(1):102. doi: 10.1038/s43856-023-00325-6.
2
Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina.
IJID Reg. 2023 Jun;7:164-169. doi: 10.1016/j.ijregi.2023.03.010. Epub 2023 Mar 22.
3
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait.
Vaccines (Basel). 2023 Feb 2;11(2):336. doi: 10.3390/vaccines11020336.
4
Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
JAMA Netw Open. 2022 Jun 1;5(6):e2218794. doi: 10.1001/jamanetworkopen.2022.18794.
5
SARS-CoV-2 prevalence at eight urban health clinics in Nicaragua: possible implications for the COVID-19 pandemic.
IJID Reg. 2022 Mar;2:110-117. doi: 10.1016/j.ijregi.2021.12.013. Epub 2022 Jan 5.
6
Burden of SARS-CoV-2 and protection from symptomatic second infection in children.
medRxiv. 2022 Jan 5:2022.01.03.22268684. doi: 10.1101/2022.01.03.22268684.
7
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Sci Transl Med. 2022 Jan 19;14(628):eabl7430. doi: 10.1126/scitranslmed.abl7430.
8
Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.
Clin Infect Dis. 2022 Aug 24;75(1):e257-e266. doi: 10.1093/cid/ciab717.
9
Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis.
J Glob Health. 2021 Jul 17;11:05013. doi: 10.7189/jogh.11.05013. eCollection 2021.
本文引用的文献
1
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
mSphere. 2021 Aug 25;6(4):e0027521. doi: 10.1128/mSphere.00275-21.
2
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2109229118.
3
Social inequalities and COVID-19 mortality in the city of São Paulo, Brazil.
Int J Epidemiol. 2021 Jul 9;50(3):732-742. doi: 10.1093/ije/dyab022.
4
COVID-19 antibody seroprevalence in Santa Clara County, California.
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
5
Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis.
Front Public Health. 2021 Jan 20;8:587374. doi: 10.3389/fpubh.2020.587374. eCollection 2020.
6
Covid-19 pandemic and the social determinants of health.
BMJ. 2021 Jan 28;372:n129. doi: 10.1136/bmj.n129.
7
First report on prevalence of SARS-CoV-2 infection among health-care workers in Nicaragua.
PLoS One. 2021 Jan 27;16(1):e0246084. doi: 10.1371/journal.pone.0246084. eCollection 2021.
8
Risk Factors and Clinical Profile of Sapovirus-associated Acute Gastroenteritis in Early Childhood: A Nicaraguan Birth Cohort Study.
Pediatr Infect Dis J. 2021 Mar 1;40(3):220-226. doi: 10.1097/INF.0000000000003015.
9
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709. doi: 10.1093/cid/ciab004.
10
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15.
Zotero 插件